this all sounds like J&J is playing one suitor against another all in a bid to wring as high a price as possible. A logical play by J&J. J&J (remember their Credo?) has spent billions settling lawsuits as a sale of OCD would certainly help offset some of those losses.
Sadly there is not much left of OCD. Any potential buyer who has done due diligence will see there is not much meat left on the bone. Thus who will over spend for the carcass that J&J created.
The Siemens comparison is an interesting one. Note that Beckman does not have any true infectious disease assays, something OCD does have though recently it seems their hepatitis A and B assays have shown to be somewhat troublesome. Looking at their pack inserts on line shows the manufacturing is performed over seas.
↧